Human ipsc-cms - OmicsDI

Show results for

Unknown (228)
Genomics (129)
Transcriptomics (78)
Proteomics (11)
Other (3)
Metabolomics (2)

Organisms

Homo sapiens (83)
Andropogon gerardi (10)
Bacteria (10)
Canis lupus familiaris (10)
Cnidaria (10)
Cricetulus griseus (10)
Eukaryota (10)
Fasciola (10)
Hepatitis B virus (10)
Human betaherpesvirus 5 (10)
Madurella mycetomatis (10)
Mesocricetus auratus (10)
Miscanthus x giganteus (10)
Mus musculus (10)
Mycobacterium tuberculosis (10)
Orthoflavivirus (10)
Panicum virgatum (10)
Platyhelminthes (10)
Pseudomonas aeruginosa AES-1R (10)
Rattus norvegicus (10)
Rattus rattus (10)
Rhodococcus jostii RHA1 (10)
Saccharomyces cerevisiae (10)
Schizosaccharomyces pombe (10)
Severe acute respiratory syndrome coronavirus 2 (10)
Sorghastrum nutans (10)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (10)
Streptococcus pneumoniae (10)
Mus musculus (8)
Macaca mulatta (2)

Organisms

Homo sapiens (84)
Mus musculus (7)
Macaca mulatta (1)
Rattus norvegicus (1)

Repository

ENA (119)
geo (79)
biostudies-arrayexpress (10)
pride (10)
MetaboLights (2)
EGA (1)
EVA (1)
MassIVE (1)

Tissue

Heart (4)
Stem cell (4)
Cardiac muscle cell (2)
Cell culture (2)
Regular ventricular cardiac myocyte (2)
Cardiomyocyte cell line (1)
Extracellular matrix (1)
Pluripotent stem cell (1)
Skin (1)

Disease

Cardiovascular system disease (1)
Dilated cardiomyopathy (1)
Disease free (1)
Heart failure (1)
Noonan syndrome (1)

Technology Type

Mass Spectrometry (10)
Shotgun proteomics (4)
Bottom-up proteomics (2)
Data-independent acquisition (2)
Gel-based experiment (2)
Mass spectrometry assay (1)
Mass spectrometry (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Data-dependent acquisition (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
Illumina HiSeq 4000 (1)
NextSeq 500 (1)
- (1)
Orbitrap Eclipse (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2024 (19)
2025 (12)
2023 (12)
2026 (12)
2022 (10)
2021 (10)
2020 (7)
2019 (6)
2014 (4)
2018 (3)
2016 (2)
2015 (2)
2017 (2)
2010 (1)

Metabolite Name

P-Hydroxyphenylethanolamine (1)
SPH(d18:0) (1)
N-Alpha-Acetyl-L-Asparagine (1)
N,N-diacetyl-O-methylhydroxylamine (1)
Indole-3-glyoxal (1)
Carnitine C4:DC (1)
20,26-dihydroxyecdysone (1)
2-Methyl-1-Pyrroline (1)
2-Aminomethylpyrimidine (1)
(1R,6S)-6-amino-5-oxocyclohexyl-2-ene-1-carboxylic-acid-ester (1)
Carnitine C5-OH (1)
Carnitine-2-methyl-C4 (1)
N-Formylglycine (1)
L-Cystathionine (1)
3,4-Dichloroaniline (1)
1-Aminocyclobutanecarboxylic acid (1)
Carnitine C2:0 (1)
(R)-2-Hydroxy-3-phenylpropionic acid (1)
L-Theanine (1)
Histidine (1)
Imidazoleacetic acid (1)
Myoinositol (1)
L-Proline (1)
LPC(0:0/15:0) (1)
2-Hexadecanoylthio-1-ethylphosphorylcholine (1)
Proline betaine (1)
Aniline (1)
Carnitine C5:0 (1)
LPC(0:0/22:4) (1)
Ammelide (1)

First Public Date

2024 (22)
2023 (20)
2026 (15)
2020 (12)
2025 (11)
2022 (11)
2021 (10)
2019 (7)
2018 (4)
2017 (2)
2015 (2)
2014 (2)
2016 (1)

Study type

Transcription profiling by array (3)
RNA-seq of total RNA (2)
RNA-seq of coding RNA (2)
Cell line - High-throughput sequencing (1)
DNA-seq (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2024 (29)
2023 (28)
2022 (26)
2025 (24)
2021 (23)
2020 (20)
2019 (18)
2015 (16)
2016 (12)
2018 (12)
2017 (11)
2014 (10)
2026 (2)
2013 (2)
2012 (2)
2011 (2)
2010 (1)

Lab affiliation

1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland (1)
Bioanalytics, Department of Clinical Chemistry, University Medical Center Goettingen (1)
Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Göttingen, Germany (1)
Department of Cardiology, Boston Children’s Hospital, Harvard Medical School (1)
GIMM – Gulbenkian Institute for Molecular Medicine (1)
Klinik und Poliklinik Innere Medizin I, Klinikum rechts der Isar - Technical University of Munich, Munich, Germany (1)
Murdoch Children's Research Institute, Melbourne, Australia (1)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (1)
Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada (1)
University Medical Center Goettingen, Institute of Clinical Chemistry, Core Facility Proteomics (1)

Previous page
1 / 46
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 46
Next page

Sort by:

Relevance

Page size

N-terminomics in NAA10 mutant iPSC-CMs

N-terminal-acetyltransferases including NAA10 catalyze N-terminal acetylation (Nt-acetylation), an evolutionarily conserved co- and post-translational modification. However, little is known about the role of Nt-acetylation in cardiac homeostasis. To gain insight into cardiac-dependent NAA10 function...

ORGANISM(S): Homo sapiens (Human)

2025-02-28 | PXD053715 | Pride

Human ipsc-cms

Rhesus iPSC-CMs response to anoxia, comparing with human iPSC-CMs

PRJNA428243 | ENA

Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs

PRJNA477344 | ENA

Transcriptomic analysis of the effect of iron overload in human iPSC-CMs

PRJNA594356 | ENA

Long non-coding RNA LIPTER effect on human iPSC-CMs and mouse heart

PRJNA732184 | ENA

Advanced iPSC-CMs maturation by integrating maturation medium, nanopatterning, and electrical stimulation

The generation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offers an unlimited source of patient-specific human cardiomyocytes. However, the use of iPSC-CM in vitro-models to guide the clinic selection of particular drugs for individual patients remains a vision. A major...

EGAS00001007491 | EGA

Transcriptomic analysis reveals a statin-induced core molecular signature in human iPSC-CMs

PRJNA451485 | ENA

Rhesus iPSC-CMs response to anoxia, comparing with human iPSC-CMs

RNA-Seq to compare hypoxia responses between human and rhesus macaque iPSC-CMs

ORGANISM(S): Macaca mulatta Homo sapiens

2018-09-10 | GSE108676 | GEO

Proteomic characterization of human iPSC-derived cardiomyocytes

Cardiomyocytes differentiated in vitro from human induced pluripotent stem cells (iPSC-CMs) are increasingly used in studies of disease mechanisms, drug development, toxicity testing, and regenerative medicine. However, the extent to which iPSC-CMs recapitulate native cardiac gene expression program...

ORGANISM(S): Homo sapiens (Human)

2025-12-30 | PXD070546 | Pride

RNA-seq of human RUES2 and iPSC derived CMs at day 15 of differentiation

PRJNA602226 | ENA

Previous page
1 / 46
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 46
Next page

Sort by:

Relevance

Page size

451 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets